...
首页> 外文期刊>Revista de microbiologia >Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria
【24h】

Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria

机译:在尼日利亚西北部卡诺市的主要医院中检测多种耐药菌

获取原文
           

摘要

Two major hospitals in Kano, North West Nigeria have recorded increasing resistance of clinical pathogens to broad spectrum β lactams, mediated by extended spectrum β- lactamase (ESβL) and non ESBLs. A study was therefore undertaken to determine the occurrence and prevalence of plasmid and chromosomal mediated AmpC βL and carbapenemase in addition to already known ESBL due to increasing resistance of pathogens from the two hospitals to carbapenems, cephamycins and flouroquinolones. Antibiogram tests and ESBL, AmpC and carbapenemase production tests were performed on all the isolates. AmpC and carbapenemase producers were further screened for AmpC inducibility and metallo beta lactamase production respectively. Majority of the isolates ( 80%) were resistant to both β-lactam and non β-lactam antibiotics. Reduced susceptibility to levofloxacin, nitrofurantoin, nalidixic acid and ofloxacin among the isolates were observed with the exception of P. aeruginosa which is totally resistant to imipenem and levofloxacin. An overall prevalence of 14.4%, 11.9% and 11.9.3% for ESβL, AmpC and carbapenemase was observed respectively. About 7.9% of the AmpC producers can over expressed the chromosomally mediated AmpC and 85.8% of the carbapenemase producers require metal for their action. Co-production of either of two and/or all of the enzymes was observed in E. coli, P. mirabilis and P. aeruginosa. Antibiotic resistance among isolates from the two hospitals is increasing and the major cause of this resistance in the pathogens studied are production of AmpC, carbapenemase (especially Metallo β- lactamase) in addition to already known ESBL enzymes by the pathogens. Some of the isolates also possess the capacity to elaborate two or more of the enzymes concurrently, which would renders them resistant to a multitude of antibiotics.
机译:尼日利亚西北部卡诺市的两家主要医院已经记录了临床病原体对广谱β-内酰胺酶(ESβL)和非ESBLs介导的广谱β-内酰胺抵抗力的增强。因此,由于两家医院的病原体对碳青霉烯,头孢霉素和氟喹诺酮类药物的耐药性增强,因此除了已知的ESBL外,还进行了一项研究以确定质粒和染色体介导的AmpCβL和碳青霉烯酶的发生和流行。对所有分离物进行了抗菌素检测以及ESBL,AmpC和碳青霉烯酶生产检测。进一步筛选了AmpC和碳青霉烯酶生产商的AmpC诱导能力和金属β内酰胺酶生产。大多数分离株(> 80%)对β-内酰胺和非β-内酰胺抗生素均具有抗性。除铜绿假单胞菌对亚胺培南和左氧氟沙星完全耐药外,其他分离株对左氧氟沙星,硝基呋喃妥因,萘啶酸和氧氟沙星的敏感性降低。 ESβL,AmpC和碳青霉烯酶的总体患病率分别为14.4%,11.9%和11.9.3%。大约7.9%的AmpC生产者可以过度表达染色体介导的AmpC,而85.8%的碳青霉烯酶生产者需要金属才能发挥作用。在大肠杆菌,奇异假单胞菌和铜绿假单胞菌中观察到两种和/或所有酶的联合生产。两家医院的分离株之间的抗生素耐药性正在增加,所研究的病原体中这种耐药性的主要原因是除病原体已知的ESBL酶外,还有AmpC,碳青霉烯酶(尤其是Metalloβ-内酰胺酶)的产生。一些分离物还具有同时加工两种或多种酶的能力,这将使它们对多种抗生素具有抗性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号